Lubin B, Lewis R
Children's Hospital Oakland Research Institute, CA 94609, USA.
Environ Health Perspect. 1995 Sep;103 Suppl 6(Suppl 6):99-104. doi: 10.1289/ehp.95103s699.
It is now possible to identify biochemical and/or cellular changes in humans due to exposure to an environmental toxin. These changes are called biomarkers and are currently used in research studies to identify individuals exposed to specific toxic substances. Advances in the field of biomarker technology may have important implications for the detection, prevention, and treatment of certain diseases in children. This technology may enable physicians to screen children who have no clinically detectable illness for evidence of exposure to specific toxins. Such information could lead to implementation of preventive measures and development of new therapeutic strategies. However, several important issues, including potential adverse consequences resulting from the widespread use of this technology, must be considered prior to its utilization within a clinical setting. Leaders of the pediatric and public health communities should recognize the paucity of scientific data in the pediatric environmental health area, and new approaches to this important aspect of child health should be developed. This article will address several of the issues involved in pediatric environmental health and consider questions that should be answered as the potential for technology transfer becomes a reality.
现在已经能够识别出人类因接触环境毒素而产生的生化和/或细胞变化。这些变化被称为生物标志物,目前在研究中用于识别接触特定有毒物质的个体。生物标志物技术领域的进展可能对儿童某些疾病的检测、预防和治疗具有重要意义。这项技术可能使医生能够对没有临床可检测疾病的儿童进行筛查,以寻找接触特定毒素的证据。此类信息可能会促使实施预防措施并制定新的治疗策略。然而,在将这项技术应用于临床之前,必须考虑几个重要问题,包括广泛使用该技术可能产生的潜在不良后果。儿科和公共卫生领域的领导者应该认识到儿科环境卫生领域科学数据的匮乏,并且应该开发针对儿童健康这一重要方面的新方法。本文将探讨儿科环境卫生中涉及的几个问题,并思考随着技术转移的可能性成为现实而应该回答的问题。